Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

REGENXBIO - Stock Price History | RGNX

Historical daily share price chart and data for REGENXBIO since 2020 adjusted for splits. The latest closing stock price for REGENXBIO as of June 01, 2020 is 36.83.
  • The all-time high REGENXBIO stock closing price was 82.15 on July 10, 2018.
  • The REGENXBIO 52-week high stock price is 55.23, which is 50% above the current share price.
  • The REGENXBIO 52-week low stock price is 20.03, which is 45.6% below the current share price.
  • The average REGENXBIO stock price for the last 52 weeks is 40.69.
  
REGENXBIO Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 44.7959 43.3300 62.4500 31.8400 40.9700 -2.34%
2018 52.0580 34.7500 82.1500 24.0500 41.9500 26.17%
2017 22.8349 18.5000 34.6000 16.7000 33.2500 79.25%
2016 13.4967 17.0000 24.0000 7.3200 18.5500 11.75%
2015 20.6147 30.4500 30.7000 14.1500 16.6000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.403B $0.035B
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.120B 14.88
Gilead Sciences (GILD) United States $97.628B 12.65
CSL (CSLLY) Australia $84.053B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.661B 51.33
Regeneron Pharmaceuticals (REGN) United States $67.420B 25.99
Illumina (ILMN) United States $53.368B 54.84
Biogen (BIIB) United States $50.113B 8.58
Seattle Genetics (SGEN) United States $27.213B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.477B 11.38
Moderna (MRNA) United States $22.830B 0.00
Incyte (INCY) United States $22.153B 0.00
Genmab (GMAB) Denmark $19.891B 16.38
Genmab (GNMSF) Denmark $19.309B 57.33
BioMarin Pharmaceutical (BMRN) United States $19.268B 174.67
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.532B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.144B 38.92
Exact Sciences (EXAS) United States $12.860B 0.00
BeiGene (BGNE) Cayman Islands $12.803B 0.00
Sarepta Therapeutics (SRPT) United States $11.875B 0.00
BioNTech SE (BNTX) Germany $11.207B 0.00
Bio-Techne Corp (TECH) United States $10.121B 66.87
QIAGEN (QGEN) Netherlands $9.973B 29.00
Horizon Therapeutics Public (HZNP) Ireland $9.678B 23.82
ARGENX SE-ADR (ARGX) Netherlands $9.384B 0.00
Guardant Health (GH) United States $8.549B 0.00
Immunomedics (IMMU) United States $7.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.743B 0.00
Exelixis (EXEL) United States $7.578B 26.57
Ascendis Pharma (ASND) Denmark $6.981B 0.00
Repligen (RGEN) United States $6.850B 120.16
Acceleron Pharma (XLRN) United States $5.319B 0.00
Adaptive Biotechnologies (ADPT) United States $4.911B 0.00
Reata Pharmaceuticals (RETA) United States $4.830B 0.00
MyoKardia (MYOK) United States $4.775B 0.00
Emergent Biosolutions (EBS) United States $4.377B 28.69
China Biologic Products (CBPO) China $4.360B 24.24
Mirati Therapeutics (MRTX) United States $4.329B 0.00
Zai Lab (ZLAB) China $4.323B 0.00
Global Blood Therapeutics (GBT) United States $4.261B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Ultragenyx Pharmaceutical (RARE) United States $4.084B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.941B 86.11
Momenta Pharmaceuticals (MNTA) United States $3.705B 0.00
Bluebird Bio (BLUE) United States $3.541B 0.00
Blueprint Medicines (BPMC) United States $3.530B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.272B 0.00
Amicus Therapeutics (FOLD) United States $3.214B 0.00
Arena Pharmaceuticals (ARNA) United States $3.009B 0.00
UniQure (QURE) Netherlands $2.976B 0.00
Denali Therapeutics (DNLI) United States $2.940B 0.00
NeoGenomics (NEO) United States $2.811B 205.31
Novavax (NVAX) United States $2.668B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Alkermes (ALKS) Ireland $2.597B 51.13
Alector (ALEC) United States $2.584B 0.00
Fate Therapeutics (FATE) United States $2.520B 0.00
Insmed (INSM) United States $2.454B 0.00
Viela Bio (VIE) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.380B 0.00
Inovio Pharmaceuticals (INO) United States $2.332B 0.00
Principia Biopharma (PRNB) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.885B 0.00
Epizyme (EPZM) United States $1.774B 0.00
Zymeworks (ZYME) Canada $1.736B 0.00
Adverum Biotechnologies (ADVM) United States $1.657B 0.00
Ligand Pharmaceuticals (LGND) United States $1.630B 63.48
Dicerna Pharmaceuticals (DRNA) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.576B 0.00
Twist Bioscience (TWST) United States $1.555B 0.00
Zealand Pharma (ZEAL) Denmark $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Akcea Therapeutics (AKCA) United States $1.506B 0.00
Mesoblast (MESO) Australia $1.490B 0.00
Editas Medicine (EDIT) United States $1.489B 0.00
Arcus Biosciences (RCUS) United States $1.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.440B 0.00
I-Mab (IMAB) China $1.423B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Intra-Cellular Therapies (ITCI) United States $1.387B 0.00
NGM Biopharmaceuticals (NGM) United States $1.344B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.322B 9.23
Beam Therapeutics (BEAM) United States $1.315B 0.00
Arvinas (ARVN) United States $1.303B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.083B 55.88
Nabriva Therapeutics AG (NBRV) Ireland $1.079B 0.00
Sorrento Therapeutics (SRNE) United States $1.059B 0.00
Compugen (CGEN) Israel $1.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Athenex (ATNX) United States $0.887B 0.00
NextCure (NXTC) United States $0.859B 0.00
Heska (HSKA) United States $0.826B 0.00
Cue Biopharma (CUE) United States $0.787B 0.00
Cellectis S.A (CLLS) France $0.784B 0.00
Alcobra (ARCT) United States $0.775B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.752B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Codexis (CDXS) United States $0.733B 0.00
Kadmon Holdings (KDMN) United States $0.711B 0.00
Retrophin (RTRX) United States $0.677B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
NantKwest (NK) United States $0.664B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Vericel (VCEL) United States $0.649B 119.83
Vanda Pharmaceuticals (VNDA) United States $0.639B 5.48
Morphic Holding (MORF) United States $0.636B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.634B 0.00
Bellus Health (BLU) Canada $0.632B 0.00
Agenus (AGEN) United States $0.624B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.585B 0.00
Frequency Therapeutics (FREQ) United States $0.576B 0.00
Athersys (ATHX) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.564B 0.00
MeiraGTx Holdings (MGTX) United States $0.554B 0.00
Scholar Rock Holding (SRRK) United States $0.550B 0.00
DBV Technologies S.A (DBVT) France $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.532B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 0.00
AnaptysBio (ANAB) United States $0.520B 0.00
VBI Vaccines (VBIV) United States $0.503B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
UROGEN PHARMA (URGN) United States $0.490B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.479B 0.00
BioDelivery Sciences (BDSI) United States $0.478B 25.16
Anika Therapeutics (ANIK) United States $0.476B 15.31
Aquinox Pharmaceuticals (NLTX) United States $0.467B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
CytomX Therapeutics (CTMX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.381B 327.00
ANI Pharmaceuticals (ANIP) United States $0.376B 7.45
Intrexon (PGEN) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Kamada (KMDA) Israel $0.349B 14.54
Avid Bioservices (CDMO) United States $0.330B 0.00
Geron (GERN) United States $0.327B 0.00
Menlo Therapeutics (MNLO) United States $0.326B 0.00
MannKind (MNKD) United States $0.322B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.316B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Verastem (VSTM) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.267B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Liquidia Technologies (LQDA) United States $0.262B 0.00
Starpharma Holdings (SPHRY) Australia $0.259B 0.00
Affimed (AFMD) Germany $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Exicure (XCUR) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
ARAVIVE, INC (ARAV) United States $0.204B 0.00
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.194B 0.00
Cerecor (CERC) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Aytu Bioscience (AYTU) United States $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Celyad SA (CYAD) Belgium $0.158B 0.00
TELA Bio (TELA) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.150B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Trevena (TRVN) United States $0.139B 0.00
Theratechnologies (THTX) Canada $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Organovo Holdings (ONVO) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Happiness Biotech Group (HAPP) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Signal Genetics (MGEN) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
OvaScience (MLND) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Curis (CRIS) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.030B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00